최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Psychiatry investigation, v.14 no.2, 2017년, pp.205 - 215
Seo, Eun Hyun (Premedical Science, College of Medicine, Chosun University, Gwangju, Republic of Korea.) , Park, Woon Yeong (National Research Center for Dementia, Chosun University, Gwangju, Republic of Korea.) , Choo, IL Han (National Research Center for Dementia, Chosun University, Gwangju, Republic of Korea.)
ObjectiveThe aim of this study was to explore the prognostic values of biomarkers of neurodegeneration as measured by magnetic resonance imaging (MRI) and amyloid burden as measured by amyloid positron emission tomography (PET) in predicting conversion to Alzheimer's disease (AD) in patients with mi...
1 Albert MS DeKosky ST Dickson D Dubois B Feldman HH Fox NC The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimers Dement 2011 7 270 279 21514249
2 Dubois B Feldman HH Jacova C Cummings JL Dekosky ST Barberger-Gateau P Revising the definition of Alzheimer’s disease: a new lexicon Lancet Neurol 2010 9 1118 1127 20934914
3 Prestia A Caroli A Wade SK van der Flier WM Ossenkoppele R Van Berckel B Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics Alzheimers Dement 2015 11 1191 1201 25646957
4 Petersen RC Smith GE Waring SC Ivnik RJ Tangalos EG Kokmen E Mild cognitive impairment: clinical characterization and outcome Arch Neurol 1999 56 303 308 10190820
5 Winblad B Palmer K Kivipelto M Jelic V Fratiglioni L Wahlund LO Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment J Intern Med 2004 256 240 246 15324367
6 McKhann G Drachman D Folstein M Katzman R Price D Stadlan EM Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 1984 34 939 944 6610841
7 American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV (4th Ed.) Washington, DC American Psychiatric Association 1994
8 Whiting PF Rutjes AW Westwood ME Mallett S Deeks JJ Reitsma JB QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Ann Intern Med 2011 155 529 536 22007046
9 Higgins JP Thompson SG Quantifying heterogeneity in a meta-analysis Stat Med 2002 21 1539 1558 12111919
10 deToledo-Morrell L Stoub TR Bulgakova M Wilson RS Bennett DA Leurgans S MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD Neurobiol Aging 2004 25 1197 1203 15312965
11 Jack CR Jr Shiung MM Weigand SD O'Brien PC Gunter JL Boeve BF Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI Neurology 2005 65 1227 1231 16247049
12 Wang PN Lirng JF Lin KN Chang FC Liu HC Prediction of Alzheimer's disease in mild cognitive impairment: a prospective study in Taiwan Neurobiol Aging 2006 27 1797 1806 16321457
13 Caroli A Testa C Geroldi C Nobili F Barnden LR Guerra UP Cerebral perfusion correlates of conversion to Alzheimer's disease in amnestic mild cognitive impairment J Neurol 2007 254 1698 1707 17990057
14 Desikan RS Fischl B Cabral HJ Kemper TL Guttmann CR Blacker D MRI measures of temporoparietal regions show differential rates of atrophy during prodromal AD Neurology 2008 71 819 825 18672473
15 Eckerstrom C Olsson E Borga M Ekholm S Ribbelin S Rolstad S Small baseline volume of left hippocampus is associated with subsequent conversion of MCI into dementia: the Goteborg MCI study J Neurol Sci 2008 272 48 59 18571674
16 Bakkour A Morris JC Dickerson BC The cortical signature of prodromal AD: regional thinning predicts mild AD dementia Neurology 2009 72 1048 1055 19109536
17 Waragai M Okamura N Furukawa K Tashiro M Furumoto S Funaki Y Comparison study of amyloid PET and voxel-based morphometry analysis in mild cognitive impairment and Alzheimer's disease J Neurol Sci 2009 285 100 108 19552926
18 Fritzsche KH Stieltjes B Schlindwein S van Bruggen T Essig M Meinzer HP Automated MR morphometry to predict Alzheimer's disease in mild cognitive impairment Int J Comput Assist Radiol Surg 2010 5 623 632 20440655
19 Galluzzi S Geroldi C Ghidoni R Paghera B Amicucci G Bonetti M The new Alzheimer's criteria in a naturalistic series of patients with mild cognitive impairment J Neurol 2010 257 2004 2014 20632026
20 Plant C Teipel SJ Oswald A Bohm C Meindl T Mourao-Miranda J Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease Neuroimage 2010 50 162 174 19961938
21 Scola E Bozzali M Agosta F Magnani G Franceschi M Sormani MP A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up J Neurol Neurosurg Psychiatry 2010 81 798 805 20392973
22 Moretti DV Frisoni GB Fracassi C Pievani M Geroldi C Binetti G MCI patients' EEGs show group differences between those who progress and those who do not progress to AD Neurobiol Aging 2011 32 563 571 20022139
23 Westman E Cavallin L Muehlboeck JS Zhang Y Mecocci P Vellas B Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease PLoS One 2011 6 e22506 21811624
24 Devanand DP Bansal R Liu J Hao X Pradhaban G Peterson BS MRI hippocampal and entorhinal cortex mapping in predicting conversion to Alzheimer's disease Neuroimage 2012 60 1622 1629 22289801
25 Munoz-Ruiz MA Hartikainen P Koikkalainen J Wolz R Julkunen V Niskanen E Structural MRI in frontotemporal dementia: comparisons between hippocampal volumetry, tensor-based morphometry and voxel-based morphometry PLoS One 2012 7 e52531 23285078
26 Thurfjell L Lotjonen J Lundqvist R Koikkalainen J Soininen H Waldemar G Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment Neurodegener Dis 2012 10 246 249 22301718
27 Bruck A Virta JR Koivunen J Koikkalainen J Scheinin NM Helenius H [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment Eur J Nucl Med Mol Imaging 2013 40 1567 1572 23801168
28 Douaud G Menke RA Gass A Monsch AU Rao A Whitcher B Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer's disease J Neurosci 2013 33 2147 2155 23365250
29 Rowe CC Bourgeat P Ellis KA Brown B Lim YY Mulligan R Predicting Alzheimer disease with beta-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing Ann Neurol 2013 74 905 913 24448836
30 Selnes P Aarsland D Bjornerud A Gjerstad L Wallin A Hessen E Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment J Alzheimers Dis 2013 33 723 736 23186987
31 Vos SJ van Rossum IA Verhey F Knol DL Soininen H Wahlund LO Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI Neurology 2013 80 1124 1132 23446677
32 Ong KT Villemagne VL Bahar-Fuchs A Lamb F Langdon N Catafau AM Abeta imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study J Neurol Neurosurg Psychiatry 2015 86 431 436 24970906
33 Varon D Barker W Loewenstein D Greig M Bohorquez A Santos I Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome Int J Geriatr Psychiatry 2015 30 192 200 24816477
34 Wolk DA Price JC Saxton JA Snitz BE James JA Lopez OL Amyloid imaging in mild cognitive impairment subtypes Ann Neurol 2009 65 557 568 19475670
35 Shao H Okamura N Sugi K Furumoto S Furukawa K Tashiro M Voxel-based analysis of amyloid positron emission tomography probe [C]BF-227 uptake in mild cognitive impairment and alzheimer's disease Dement Geriatr Cogn Disord 2010 30 101 111 20733303
36 Doraiswamy PM Sperling RA Coleman RE Johnson KA Reiman EM Davis MD Amyloid-beta assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study Neurology 2012 79 1636 1644 22786606
37 Hatashita S Yamasaki H Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction PLoS One 2013 8 e66877 23799136
38 Nordberg A Carter SF Rinne J Drzezga A Brooks DJ Vandenberghe R A European multicentre PET study of fibrillar amyloid in Alzheimer's disease Eur J Nucl Med Mol Imaging 2013 40 104 114 22961445
39 Trzepacz PT Yu P Sun J Schuh K Case M Witte MM Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia Neurobiol Aging 2014 35 143 151 23954175
40 Yuan Y Gu ZX Wei WS Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis AJNR Am J Neuroradiol 2009 30 404 410 19001534
41 Zhang S Han D Tan X Feng J Guo Y Ding Y Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment Int J Clin Pract 2012 66 185 198 22257044
42 Chen X Li M Wang S Zhu H Xiong Y Liu X Pittsburgh compound B retention and progression of cognitive status--a meta-analysis Eur J Neurol 2014 21 1060 1067 24612390
43 Prestia A Caroli A van der Flier WM Ossenkoppele R Van Berckel B Barkhof F Prediction of dementia in MCI patients based on core diagnostic markers for Alzheimer disease Neurology 2013 80 1048 1056 23390179
44 Dubois B Feldman HH Jacova C Dekosky ST Barberger-Gateau P Cummings J Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 2007 6 734 746 17616482
45 Whitwell JL Shiung MM Przybelski SA Weigand SD Knopman DS Boeve BF MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment Neurology 2008 70 512 520 17898323
46 Reisberg B Ferris SH de Leon MJ Crook T The Global Deterioration Scale for assessment of primary degenerative dementia Am J Psychiatry 1982 139 1136 1139 7114305
47 Petersen RC Mild cognitive impairment or questionable dementia? Arch Neurol 2000 57 643 614 10815128
48 Levy R Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization Int Psychogeriatr 1994 6 63 68 8054494
49 Petersen RC Doody R Kurz A Mohs RC Morris JC Rabins PV Current concepts in mild cognitive impairment Arch Neurol 2001 58 1985 1992 11735772
50 Dubois B Feldman HH Jacova C Dekosky ST Barberger-Gateau P Cummings J Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 2007 6 734 746 17616482
51 Petersen RC Mild cognitive impairment as a diagnostic entity J Intern Med 2004 256 183 194 15324362
※ AI-Helper는 부적절한 답변을 할 수 있습니다.